Clinical trial
Interventional, Open-label, Flexible-dose Study of Vortioxetine on Emotional Functioning in Patients With Major Depressive Disorder With Inadequate Response to SSRI/SNRI Treatment
NCT03835715 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional, Open-label, Flexible-dose Study of Vortioxetine on Emotional Functioning in Patients With Major Depressive Disorder With Inadequate Response to SSRI/SNRI Treatment
- Lead sponsor
- H. Lundbeck A/S
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 5, 2019
- Completion date
- February 21, 2020
- Enrollment
- 150 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.